semaglutide and addiction Semaglutide… for alcohol use disorder? 👀, A major 2025 randomized trial showed:, ⬇️ Heavy drinking days, ⬇️ Cravings, ⬇️ Alcohol consumption, This challenges how we think about addiction—and who might GLP-1 Alcohol Cravings: How Ozempic

NAFLD could be considered an hepatic manifestation of metabolic syndrome, given the strong association with obesity, type 2 diabetes, hypertension and dyslipidaemia (3)

The recent availability of generics has certainly accelerated interest, but these are not lifestyle or cosmetic drugs for indiscriminate weight loss

15 Tirzepatide (Mounjaro, Zepbound) is a related medication that mimics both GLP-1 and another gut hormone called GIP (glucose-dependent insulinotropic polypeptide), potentially leading to even greater weight loss effects for some individuals

Researchers found that GLP-1 receptor agonism significantly reduces Cyp2e1 expression in animal models, with reductions of 40-60% observed

Additionally, the injection pen design simplifies handling procedures in controlled settings

The titration schedule for microdosing semaglutide (Ozempic) is as follows: Week 1-4: 0.05 mg weekly Week 5-8: 0.1 mg weekly Week 9-12: 0.2 mg weekly The titration schedule for semaglutide (Ozempic microdosing) may be prescribed as follows: Ozempic microdosing Tirzepatide microdosing: Craig Koniver, MD, a physician based in South Carolina, suggests that tirzepatide microdoses for weight loss can be approximately 60% of the standard starting dose for women and 72% for men